Safety and efficacy of casein kinase 1α and cyclin dependent kinase 7/9 inhibition in patients with relapsed or refractory AML: A first-in-human study of BTX-A51 Meeting Abstract
| Authors: | Ball, B.; Borthakur, G.; Stein, A. S.; Chan, K.; Thai, D. L.; Stein, E. |
| Abstract Title: | Safety and efficacy of casein kinase 1α and cyclin dependent kinase 7/9 inhibition in patients with relapsed or refractory AML: A first-in-human study of BTX-A51 |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301931 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.7030 |
| Notes: | Meeting Abstract: 7030 -- This meeting was also held virtually -- Source: Wos |
